Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6MHP vaccine plus ipilimumab in melanoma
NCT02385669Phase 2Terminated
- Start
- Apr 2015
- Primary completion
- Sep 2019
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of melanoma helper peptide vaccine in melanoma. Started Apr 2015; status: terminated.
02
Drugs
melanoma helper peptide vaccine
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02385669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02385669.